{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:20:11Z","timestamp":1790104811543,"version":"4.0.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Small intestinal bacterial overgrowth (SIBO), characterized by alterations in both the type and quantity of bacteria in the small intestine, leads to impaired intestinal digestion and absorption that can cause a range of clinical symptoms. Recent studies have identified significant changes in the composition of the small intestinal microbiota and metabolomic profiles of patients with metabolic dysfunction-associated steatotic liver disease (MASLD). This study systematically reviewed and synthesized the available data to explore the association between SIBO and MASLD. Comprehensive literature searches of the Embase, PubMed, Web of Science, Ovid, and Cochrane databases were conducted. Article quality screening was performed using the Newcastle-Ottawa Quality Assessment Scale. Cross-sectional, cohort, and case\u2013control studies were included. A total of 7,200 articles were initially screened, of which 14 were ultimately included for analysis. Individuals with SIBO in both the MASLD and non-MASLD groups were extracted and a chi-square test was performed to calculate the odds ratio (OR) and 95% confidence interval (CI). The I<jats:sup>2<\/jats:sup> index was used to measure heterogeneity. For heterogeneity &amp;gt;50%, a random effects model was used. There was a clear association between SIBO and MASLD (OR\u202f=\u202f3.09; 95% CI 2.09\u20134.59, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u202f=\u202f66%, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001). Subgroup analyses by MASLD stage showed that the probability of SIBO positivity increased with MASLD lesion severity. After stratifying by the diagnostic methods for SIBO and MASLD, the meta-analysis results suggest a reduction in inter-group heterogeneity. For the MASLD subgroup diagnosed via liver biopsy, the OR was 4.89. A subgroup analysis of four studies that included intestinal permeability testing revealed an OR of 3.86 (95% CI: 1.80\u20138.28, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u202f=\u202f9%, <jats:italic>p<\/jats:italic>\u202f=\u202f0.0005). A meta-regression analyses revealed that both race and regional development level significantly influenced the relationship between SIBO and MASLD (<jats:italic>p<\/jats:italic>\u202f=\u202f0.010, <jats:italic>p<\/jats:italic>\u202f=\u202f0.047). In conclusion, this meta-analyses provides strong evidence that SIBO may contribute to the development and progression of MASLD. The strongest associations were observed between lactulose breath testing, gut microbiota culture, liver biopsy diagnosis of MASLD, and SIBO detected through intestinal permeability testing. The primary sources of heterogeneity are race and developed regions.<\/jats:p><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=427040<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2024.1502151","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T05:11:25Z","timestamp":1734412285000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Small intestinal bacterial overgrowth and metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Ziteng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e8860","DOI":"10.7759\/cureus.8860","article-title":"Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods","volume":"12","author":"Achufusi","year":"2020","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.dsx.2018.03.016","article-title":"Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors","volume":"12","author":"Al-Dayyat","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/0002-9343(66)90226-9","article-title":"Postgastrectomy blind loop syndrome. Megaloblastic anemia secondary to malabsorption of folic acid","volume":"41","author":"Barrett","year":"1966","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1515\/jpem-2017-0252","article-title":"The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents","volume":"30","author":"Belei","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.freeradbiomed.2021.12.006","article-title":"The antioxidant tempol transforms gut microbiome to resist obesity in female C3H mice fed a high fat diet","volume":"178","author":"Choudhuri","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cca.2015.01.003","article-title":"The role of the gut microbiome in the healthy adult status","volume":"451","author":"D\u2019Argenio","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.15403\/jgld-497","article-title":"Non-alcoholic steatohepatitis: comparison of intestinal microbiota between different metabolic profiles. A pilot study","volume":"29","author":"De Oliveira","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0016-5085(69)80067-3","article-title":"Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons","volume":"56","author":"Drasar","year":"1969","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2036.2009.03970.x","article-title":"Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea","volume":"29","author":"Fan","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000103892","article-title":"Small intestinal bacterial overgrowth: diagnosis and treatment","volume":"25","author":"Gasbarrini","year":"2007","journal-title":"Dig Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12664-017-0797-6","article-title":"Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture","volume":"36","author":"Ghoshal","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/gut.8.6.530","article-title":"Population control in the small bowel","volume":"8","author":"Gorbach","year":"1967","journal-title":"Gut"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.3390\/nu14245261","article-title":"The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis-a systematic review, meta-analysis and meta-regression","volume":"14","author":"Gudan","year":"2022","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/bib\/bbs020","article-title":"Metagenomic analysis: the challenge of the data bonanza","volume":"13","author":"Hunter","year":"2012","journal-title":"Brief Bioinform"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH. E.M.B.O","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"Mol Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.mayocp.2016.07.025","article-title":"Small intestinal bacterial overgrowth: a primary care review","volume":"91","author":"Krajicek","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.3390\/nu6125583","article-title":"The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease","volume":"6","author":"Ferolla","year":"2014","journal-title":"Nutrients"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.15403\/jgld.2014.1121.252.iwg","article-title":"Small intestinal bacterial overgrowth is associated with non-alcoholic fatty liver disease","volume":"25","author":"Fialho","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1615\/IntJMedMushrooms.2021037945","article-title":"Bioactive components and possible activities of medicinal mushrooms in alleviating the pathogenesis of nonalcoholic fatty liver disease (review)","volume":"23","author":"Lo","year":"2021","journal-title":"Int J Med Mushrooms"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0183282","DOI":"10.1371\/journal.pone.0183282","article-title":"Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: studies in children","volume":"12","author":"Nier","year":"2017","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","article-title":"High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis","volume":"18","author":"Sabat\u00e9","year":"2008","journal-title":"Obes Surg"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","article-title":"Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8","volume":"56","author":"Shanab","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1097\/MEG.0000000000002157","article-title":"Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease","volume":"33","author":"Shi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.36740\/WLek201903107","article-title":"Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children","volume":"72","author":"Stepanov","year":"2019","journal-title":"Wiad Lek"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/microorganisms11030723","article-title":"Prevalence of small intestinal bacterial overgrowth syndrome in patients with non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: a cross-sectional study","volume":"11","author":"Gkolfakis","year":"2023","journal-title":"Microorganisms"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12876-019-0960-x","article-title":"The role of small intestinal bacterial overgrowth (SIBO) in non-alcoholic fatty liver disease (NAFLD) patients evaluated using controlled attenuation parameter (CAP) transient elastography (TE): a tertiary referral center experience","volume":"19","author":"Fitriakusumah","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e13947","DOI":"10.1111\/ijcp.13947","article-title":"Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy","volume":"75","author":"Mikolasevic","year":"2021","journal-title":"Int J Clin Pract"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1376148","DOI":"10.3389\/fmed.2024.1376148","article-title":"Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study","volume":"11","author":"Ortiz-L\u00f3pez","year":"2024","journal-title":"Front Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/nu9050485","article-title":"Urinary metabolomics in pediatric obesity and nafld identifies metabolic pathways\/metabolites related to dietary habits and gut-liver axis perturbations","volume":"9","author":"Troisi","year":"2017","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fpsyt.2020.00664","article-title":"Small intestinal bacterial overgrowth and irritable bowel syndrome - an update","volume":"11","author":"Takakura","year":"2020","journal-title":"Front Psych"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MEG.0000000000001541","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"32","author":"Wijarnpreecha","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-0036-1593883","article-title":"Microbiome-host immune system interactions","volume":"36","author":"Smolinska","year":"2016","journal-title":"Semin Liver Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/srep00170","article-title":"Bacterial biogeography of the human digestive tract","volume":"1","author":"Stearns","year":"2011","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"E1032","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling","volume":"320","author":"Xie","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/ajcn\/25.12.1409","article-title":"The metabolic and nutritional consequences of bacterial overgrowth in the small intestine","volume":"25","author":"Neale","year":"1972","journal-title":"Am J Clin Nutr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1381\/096089205774512582","article-title":"The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery","volume":"15","author":"Ziolkowski","year":"2005","journal-title":"Obes Surg"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0260479","DOI":"10.1371\/journal.pone.0260479","article-title":"Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: a meta-analysis","volume":"16","author":"Kuang","year":"2021","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"AGA clinical practice update on small intestinal bacterial overgrowth: expert review","volume":"159","author":"Quigley","year":"2020","journal-title":"Gastroenterology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1053\/j.gastro.2022.04.002","article-title":"Small intestinal bacterial overgrowth-pathophysiology and its implications for definition and management","volume":"163","author":"Bushyhead","year":"2022","journal-title":"Gastroenterology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"gutjnl-2023-330595","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2307568","DOI":"10.1080\/19490976.2024.2307568","article-title":"Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation","volume":"16","author":"Min","year":"2024","journal-title":"Gut Microbes"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3350\/cmh.2024.0315","article-title":"Immunological mechanisms in steatotic liver diseases: an overview and clinical perspectives","volume":"30","author":"Yan","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated Steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3350\/cmh.2024.0565","article-title":"Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: letter to the editor on \"differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study\"","volume":"30","author":"Chang","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/ijms242316654","article-title":"Transcriptomics of MASLD pathobiology in African American patients in the Washington DC area \u2020","volume":"69","author":"Mondal","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e0324","DOI":"10.1097\/HC9.0000000000000324","article-title":"Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States","volume":"7","author":"Ochoa-Allemant","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s10620-024-08540-4","article-title":"Sex and race-ethnic disparities in metabolic dysfunction-associated Steatotic liver disease: an analysis of 40,166 individuals","volume":"69","author":"Fu","year":"2024","journal-title":"Dig Dis Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"fuad022","DOI":"10.1093\/femsre\/fuad022","article-title":"The small intestine: dining table of host-microbiota meetings","volume":"47","author":"Delbaere","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","article-title":"Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids","volume":"23","author":"Martinez-Guryn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/19490976.2018.1502539","article-title":"Small intestinal microbiota: the neglected stepchild needed for fat digestion and absorption","volume":"10","author":"Chang","year":"2019","journal-title":"Gut Microbes"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/00365521.2015.1086020","article-title":"Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey","volume":"51","author":"Ierardi","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.3390\/nu15184035","article-title":"Influence of body composition and specific anthropometric parameters on SIBO type","volume":"15","author":"Wielgosz-Grochowska","year":"2023","journal-title":"Nutrients"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2018.1465157","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00018-015-2061-5","article-title":"Gut microbiota and obesity","volume":"73","author":"G\u00e9rard","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"122211","DOI":"10.1016\/j.lfs.2023.122211","article-title":"Gut microbiota in obesity and related complications: unveiling the complex interplay","volume":"334","author":"Islam","year":"2023","journal-title":"Life Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1502151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T05:11:35Z","timestamp":1734412295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1502151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":68,"alternative-id":["10.3389\/fnut.2024.1502151"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1502151","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"article-number":"1502151"}}